⌘K

Login Start Free

Home/Filings/4/0001209191-21-033829

4//SEC Filing

Friedman Bart 4

Accession 0001209191-21-033829

CIK 0001636651other

View on SEC.gov Company Profile

Filed

May 17, 8:00 PM ET

Accepted

May 18, 9:00 PM ET

Size

5.3 KB

Accession

0001209191-21-033829

Insider Transaction Report

Form 4

Period: 2021-05-17

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2021-05-17+1,750→ 1,750 total
Exercise: $3.67Exp: 2031-05-16→ Common Stock (1,750 underlying)

Footnotes (1)

[F1]The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: May 17, 8:00 PM ET
Accepted: May 18, 9:00 PM ET
Size: 5.3 KB

View on SEC.gov